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Thyroid hormone (TH) action is mediated principally through binding of the hormone ligand,
3,3,5-triiodothyronine (T3), to TH receptors (TRs).This hormone-receptor interaction recruits other proteins
to form complexes that regulate gene expression by binding to DNA sequences in the promoter of target
genes.We recently described an extranuclear mechanism of TH action that consists of the association of
TH-liganded TRβ with p85α [regulatory subunit of phosphatidylinositol 3-kinase (PI3K)] in the cytosol and
subsequent activation of the PI3K, generating phosphatidylinositol 3,4,5-triphosphate [PtdIns(3,4,5)P3].This
initiates the activation of a signaling cascade by phosphorylation of Akt, mammalian target of rapamycin
(mTOR) and its substrate p70S6K, leading to the stimulation of ZAKI-4α synthesis, a calcineurin inhibitor.
Furthermore, we found that this same mechanism leads to induction of the transcription factor hypoxia-inducible
factor (HIF-1α), and its target genes, glucose transporter (GLUT)1, platelet-type phosphofructokinase (PFKP),
and monocarboxylate transporter (MCT) 4.These genes are of special interest, because their products have
important roles in cellular glucose metabolism, from glucose uptake (GLUT1) to glycolysis (PFKP) and lactate
export (MCT4).These results demonstrate that the TH-TRβ complex can exert a non-genomic action in the
cytosol leading to changes in gene expression by direct (HIF-1α) and indirect (ZAKI-4α, GLUT1, PFKP) means.
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Classical, genomic, thyroid hormone
action
Thyroid hormone (TH) is essential for normal
development, growth and metabolism. Its effects are
mediated principally through triiodothyronine (T3), which
acts as a ligand for the TH receptors (TRs) β1, β2 and
α1 [Harvey and Williams, 2002;Yen, 2001].
In the classical model of genes positively regulated by
TH, the TR first binds as a heterodimer or homodimer on
TH response elements (TRE) located in the promoter
regions of target genes, where it interacts with
corepressors.
Upon ligand binding, the TR homodimers are dissociated
in favor of heterodimer formation with the retinoid-X
receptor (RXR), resulting in release of the corepressors
and recruitment of coactivators.This new complex attracts
a large number of proteins which engage the RNA
polymerase II in the transcription of the targeted gene
(Figure 1, part 1).This classical mechanism can also lead
to increased expression of genes devoid of TREs, if they
are target genes for transcription factors that are induced
by this mechanism.
Nongenomic action of thyroid hormone
In addition to the classical, “nuclear” mode of TH action,
a number of rapid effects taking place in the cytosol and
at the plasma membrane have been subsequently
identified.TH can control Ca
2+ entry, intracellular protein
trafficking and regulation of protein kinase C [Davis and
Davis, 2002; Davis et al., 2002].The MAPK pathway can
be activated by TH binding to the integrin αVβ3, located
in the cell membrane, without entering the cell.This
mechanism leads to phosphorylation of nuclear receptors
and can induce angiogenesis and promote cell growth
[Bergh et al., 2005;Tang et al., 2004]. A derivative of TH,
3-iodothyronamine (T1AM), can induce bradycardia and
hypothermia within minutes through a mechanism that
remains unknown [Scanlan et al., 2004].These
nongenomic actions of TH are mostly extranuclear,
appear to be independent of TRs and have rapid effects
on proteins rather than modulate gene expression.
Cytosolic activation of the PI3K pathway
by TR
As all proteins, TRs are synthesized in the cytoplasm
from where they are translocated into the nucleus to exert
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Perspective  Nuclear Receptor Signaling  |  The Open Access Journal of the Nuclear Receptor Signaling AtlasFigure 1.  Genomic and non-genomic action of TH Genomic (1) and non-genomic (2) actions of TH are illustrated. Genomic action requires
thyroid hormone responsive elements (TREs) for the recognition of genes for direct transcriptional regulation. Non-genomic action is initiated by the
TH-dependent activation of PI3K as illustrated in Figure 2. Activation of PI3K leads to sequential activation of Akt/PKB-mTOR-p70
S6K. Although not well
defined, this cascade leads to transcriptional upregulation of some genes such as ZAKI-4α and HIF-1α. GTF: general transcription factors. For details
see text.
their genomic effect summarized above. A dynamic
nucleo-cytoplasmic shuttling has been described
[Baumann et al., 2001].We recently identified a new
mechanism of TH action in which the liganded TRβ
interacts with the regulatory subunit of PI3K (p85α ) in
the cytosol [Cao et al., 2005] (Figure 2).This leads to
activation of PI3K (Figure 2) and its downstream signaling
cascade (Figure 1 part 2), sequential phosphorylation
and activation of the serine/threonine kinase Akt,
mammalian target of rapamycin (mTOR) and its substrate
p70
S6K. mTOR activation is rapid, with detectable
phosphorylation as early as 10 minutes after T3 treatment,
and not sensitive to cycloheximide (CHX) treatment,
indicating that this effect of TH uses preexisting proteins.
TH acts through the TRβ, because in human fibroblasts
that express the WT TRβ, introduction of a dominant
negative mutant TRβ abrogated the effect of TH.
Furthermore, a direct interaction between TRβ and PI3K
could be demonstrated by coimmunoprecipitation of TRβ1
with the p85α subunit of PI3K. However, activation of
PI3K requires the presence of T3.The interaction between
TRβ and PI3K most likely takes place in the cytosol.
Within minutes after activation by T3, phosphorylated Akt,
as part of the PI3K pathway, is translocated from the
cytosol into the nucleus (Figure 1 part 2).This TH action
is very rapid and independent of protein synthesis, which
is typical of nongenomic action.Yet, two aspects
distinguish this mechanism of TH action from most other
nongenomic effects of the hormone: 1) it requires TR
binding and 2) its ultimate effect is ‘genomic’ with specific
genes induced by this mechanism. For example, the
calcineurin inhibitor ZAKI-4α had been previously
described as a TH responsive gene [Cao et al., 2002;
Cao and Seo, 2003; Miyazaki et al., 1996].This effect
was blocked by inhibitors of PI3K and by a dominant
negative p85α subunit of PI3K [Cao et al., 2005].
Rapamycin, an inhibitor of mTOR also abrogated the
TH-dependent induction of ZAKI-4α, suggesting the
requirement of sequential activation of kinases initiated
by the activation of PI3K. ZAKI-4α expression is also CHX
sensitive, indicating that protein synthesis is necessary
for the induction of ZAKI-4α.These results show that
ZAKI-4α represents an example of an indirectly induced
gene downstream of nongenomic action of TH.The
transcription factor linking the PI3K pathway to ZAKI-4α
expression has not yet been identified. A similar activation
of PI3K has been observed for other steroid hormone
nuclear receptors [Simoncini et al., 2000].
TH target genes
To determine the broad scale effect of TH on gene
expression in normal human cells, we measured the
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Perspective TR  mediated PI3K activationFigure 2. TH-dependent activation of PI3K TR present in the cytosol forms a complex with p85α subunit (regulatory subunit of PI3K) in a ligand
independent manner. Ligand binding activates PI3K, generating phosphatidyl inositol-3,4,5-triphosphate (PtdIns(3,4,5)P3 from PtdIns(4,5)P2. PI3K
activity is blocked by specific inhibitors such as wortmannin or LY294002.
expression of more than 15,000 genes in fibroblasts of
normal individuals by quantitative fluorescent cDNA
microarray [Moeller et al., 2005b]. Fibroblasts from two
subjects with resistance to thyroid hormone (RTH) due
to mutations in the TRβ gene were used to confirm the
specificity of the hormonal effect by the ability to
discriminate between normal cells and cells with a defect
in TH action. Microarray analysis identified 91
up-regulated and 5 down-regulated genes and
confirmation by real-time PCR was obtained in 8 of 10
induced and 2 of 3 repressed genes that were tested.
Several new TH responsive genes were identified, both
positively (AKR1C1-3, PFKP, RAB3B, HIF-1α, COLVIA3)
and negatively regulated (FGF7, ADH1B). Genes that
had been found to respond to TH in other species were
also found in these human cells (BTEB1, GLUT1, MCT4).
Further evidence for T3-specific induction was provided
by a graded dose response for induced genes that was
absent in fibroblasts from the patients with RTH. Of
special interest among the upregulated genes were the
transcription factor subunit hypoxia-inducible factor
(HIF)-1α, its target genes, glucose transporter (GLUT)1
and platelet-type phosphofructokinase (PFKP), and the
monocarboxylate transporter (MCT)4.These genes are
functionally related as they have important roles in cellular
glucose metabolism, from glucose uptake (GLUT1) to
glycolysis (PFKP) and lactate export (MCT4).The
response of these genes to TH was reduced or absent
in the TH resistant fibroblasts, which confirms the role of
the TRβ.
The cytosolic action of TH induces
HIF-1α and glycolytic genes
The transcription factor HIF-1 consists of two subunits,
α and β.While the β subunit is constitutively expressed,
the α subunit is tightly regulated. Cellular hypoxia leads
to increase of HIF-1α protein levels by decreased
ubiquitination [Semenza, 2001] and in normoxia, growth
factors and hormones (e.g. EGF, IGF-1, insulin,
androgens) lead to increased HIF-1α by
posttranscriptional mechanisms [Bardos and Ashcroft,
2004; Kasuno et al., 2004].The latter is mediated by
cellular signal transduction pathways, especially the
PI3K-Akt/PKB-mTOR pathway and the MAPK pathways
[Fukuda et al., 2002; Kasuno et al., 2004].We examined
the involvement of the PI3K pathway by treating human
skin fibroblasts with T3. In contrast to the response to
growth factors, TH increased HIF-1α mRNA levels. mRNA
of HIF-1α was increased after 3 hours and the effect
lasted for the 24 hours of the experiments. mRNA
induction led to significant increase in the protein,
demonstrated by western blotting for HIF-1α as well as
PFKP. Addition of the PI3K inhibitor LY294002 abrogated
TH-dependent induction of mRNAs for HIF-1α as well as
GLUT1, PFKP and MCT4 [Moeller et al., 2005a]. HIF-1α
induction was direct and translation-independent, as CHX
pretreatment did not inhibit HIF-1α mRNA increase after
T3 treatment. As expected, expression of HIF-1’s target
genes, GLUT1 and PFKP, was CHX-sensitive.The MAPK
pathway was examined by pretreatment with PD98059,
but inhibition of T3 effect was not observed.The MAPK
pathway seems not to be involved expression of these
genes in human fibroblasts.These results further
demonstrate that activation of the PI3K signaling pathway
by TH and TRβ in the cytosol can lead to direct (HIF-1α)
and indirect (GLUT1, PFKP, MCT4) gene expression.
Conclusion and perspective
Until recently, TH-mediated changes in gene expression
were thought to be primarily, if not solely, initiated by
direct nuclear TR binding to a TRE in the promoter of a
target gene.We found that the same TRβ can also exert
extranuclear actions. It is capable of activating cellular
signaling pathways in the cytosol, as demonstrated for
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HIF-1α and its target genes.This cytosolic mechanism
of TH-mediated TRβ-dependent action contributes to the
overall effect of TH on gene expression. Surprisingly,
some of the most highly induced genes in our experiments
were later found to be downstream of the PI3K pathway
(e.g. ZAKI-4α, PFKP). A possible explanation is that
kinase cascades have the potential to amplify the signal
from kinase to kinase, whereas on a TRE amplification
steps are limited.The definition of the TRs therefore has
broadened beyond being merely ligand-dependent
nuclear transcription factors.We conclude that TH
responsive genes can be directly induced by nuclear (e.g.
BTEB1) and cytosolic action of TH (e.g. HIF-1α) without
requirement of prior protein synthesis. Indirectly induced
genes, following expression of a transcription factor, exist
for both modes of TH action.We expect that more
TH-responsive genes will be described as
‘nongenomically’ induced and that more signaling
pathways will be found to be activated by the TRs.
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